Lifesensors Inc.
Malvern, PA Doing business as Gene Transcription TECH
- UEI
- ECPPNPPB5U31
- CAGE
- 1TU88
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 271 Great Valley Pkwy, Malvern, PA 19355, USA
- Website
- lifesensors.com
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Progenra Inc. | Malvern, PA | — |
| Antibodies-Online Inc. | Royersford, PA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Bellbrook Labs LLC | Madison, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Dotquant LLC | Shoreline, WA | — |
| Creative Biotherapeutics LLC | Gurnee, IL | — |
About the company
Lifesensors Inc., registered in SAM.gov since 2002 and located in Malvern, Pennsylvania, is a biotechnology company specializing in ubiquitin and ubiquitin-like protein research tools and services. As a for-profit, Subchapter S corporation, the company focuses on developing advanced molecular technologies for protein research and therapeutic applications. Their primary expertise lies in creating innovative approaches to protein degradation, with a particular emphasis on developing novel molecular methods that can potentially transform drug discovery and treatment strategies for complex diseases.
The company has been awarded multiple federal grants from prestigious agencies, including the National Institute of General Medical Sciences (NIGMS), National Institute on Aging, and National Institute of Allergy and Infectious Diseases. These grants, totaling several hundred thousand dollars, support cutting-edge research in targeted protein degradation technologies. Specifically, Lifesensors Inc. has conducted research on molecular glue degraders for LRRK2 protein related to Parkinson's disease, developed novel approaches for PROTAC (Proteolysis Targeting Chimeras) drug discovery targeting neurodegenerative conditions like Alzheimer's and frontotemporal dementia, and explored non-conventional PROTAC methodologies. Their grant-funded work demonstrates a sophisticated approach to understanding protein ubiquitination, developing high-throughput screening methods, and creating innovative technologies that could potentially revolutionize treatment strategies for complex diseases by enabling more precise protein degradation mechanisms.
Quick answers
Is Lifesensors Inc. registered in SAM.gov?
Yes. Lifesensors Inc.'s SAM.gov registration is active through February 23, 2027.
What is Lifesensors Inc.'s most recent federal award?
Lifesensors Inc.'s most recent federal grant award is Molecular glue degraders for LRRK2 - hijacking the ubiquitin proteasome system (UPS) to degrade undruggable proteins… (R43GM156150), from National Institute of General Medical Sciences (NIH), on September 1, 2024.
On GovTribe
See Lifesensors Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors